Influenza: marketing vaccine by marketing disease

June 2, 2013 By Leave a Comment
Vaccine Science

By Peter Doshi, Postdoctoral Fellow: BMJ 2013;346:f3037 The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so. Promotion of influenza vaccines is one of the most visible and aggressive public health policies [...]

[Continue reading...]
Filed Under: Immunization Practices, Vaccine Related Research Tagged With: ,

Neurologic adverse events following vaccination

May 29, 2013 By Leave a Comment
science-health[1]

Prog Health Sci 2012, Vol 2 , No1 Neurologic adverse events vaccination Sienkiewicz D.*, Kułak W., Okurowska-Zawada B., Paszko-Patej G. Department of Pediatric Rehabilitation of the Medical University of Bialystok, Poland Abstract The present review summarizes data on  neurological adverse events following vaccination in the relation to intensity, time of onset, taking into account the [...]

[Continue reading...]
Filed Under: Immunization Practices, Neurology Tagged With: ,

Vaccines and Medications: Undue Pharmaceutical Manufacturers’ Influence

May 6, 2013 By 1 Comment
Trust me?

Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Stamatakis E, Weiler R, Ioannidis JP. Source Department of Epidemiology and Public Health, University College London, London, UK; Prevention Research Collaboration, School of Public Health, University of Sydney, Sydney, NSW, Australia. Abstract BACKGROUND: Expenditure on industry products (mostly drugs and devices) has spiraled over [...]

[Continue reading...]
Filed Under: Vaccine Related Research, World News Tagged With: ,

How Aluminum Nanoparticles in Vaccines Reach the Brain

April 29, 2013 By Leave a Comment
Vaccine Science

“Intramuscular injection of alum-containing vaccine was associated with the appearance of aluminum deposits in distant organs, such as spleen and brain where they were still detected one year after injection.” How does this happen? What are the potential risks? Read the study below: Slow CCL2-dependent translocation of biopersistent particles from muscle to brain Zakir Khan1,2, Christophe [...]

[Continue reading...]
Filed Under: Aluminum Adjuvants, World News Tagged With: ,

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells

April 18, 2013 By Leave a Comment
Trust me?

Amy S. McKeea,b,  Matthew A. Burchillb, Michael W. Munksb, Lei Jinc, John W. Kapplerb,c,d,Rachel S. Friedmanc, Jordan Jacobellic, and Philippa Marrackb,c,e,1 Significance Alum has been used to improve the efficacy of vaccines since the 1930s. Here we show that alum acts in part via host DNA to increase the interaction time between T cells and APCs. Abstract Many vaccines include [...]

[Continue reading...]
Filed Under: Aluminum Adjuvants Tagged With: ,

Review: Bacteria and tumours, causative agents or opportunistic inhabitants?

April 9, 2013 By Leave a Comment
IAC-logo

Joanne Cummins and Mark Tangney Infectious Agents and Cancer 2013, 8:11 doi:10.1186/1750-9378-8-11 Published: 28 March 2013 Abstract (provisional)  Associations between different bacteria and various tumours have been reported in patients for decades. Studies involving characterisation of bacteria within tumour tissues have traditionally been in the context of tumourigenesis as a result of bacterial presence within healthy tissues, and in general, [...]

[Continue reading...]
Filed Under: Cancer Research Tagged With: , , ,

Topological conformational changes of human papillomavirus (HPV) DNA bound to an insoluble aluminum salt—A study by low temperature PCR

March 5, 2013 By Leave a Comment
Gardasil Cervarix HPV Vaccine Survey

Author(s):  Sin Hang Lee ABSTRACT A low temperature (LoTemp®) polymerase chain reaction (PCR), conducted at cycling temperatures not to exceed 85℃and catalyzed by a novel highly processive HiFi® DNA polymerase with proofreading function, was used to study the topological conformational changes of the human papillomavirus (HPV) L1 gene DNA fragments bound to the insoluble amorphous aluminum [...]

[Continue reading...]
Filed Under: HPV Science, Human Papillomavirus Research, World News Tagged With: , ,

HPV vaccines and cancer prevention, science versus activism

February 4, 2013 By Leave a Comment
Trust me?

Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw Infectious Agents and Cancer 2013, 8:6 doi:10.1186/1750-9378-8-6 Published: 1 February 2013 Abstract (provisional) The rationale behind current worldwide human papilloma virus (HPV) vaccination programs starts from two basic premises, 1) that HPV vaccines will prevent cervical cancers and save lives and, 2) have no risk of serious side effects. Therefore, efforts [...]

[Continue reading...]
Filed Under: HPV, HPV Science, Immunization Practices, Vaccine Related Research, Vaccine Science, World News Tagged With: , ,

Self-Organized Criticality Theory of Autoimmuity

December 10, 2012 By Leave a Comment
PLOS-One-logo

Ken Tsumiyama1, Yumi Miyazaki1, Shunichi Shiozawa1,2,3,4* 1 Department of Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan, 2 Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 3 The Center for Rheumatic Diseases, Kobe University Hospital, Kobe, Japan, 4 Global Center of Excellence (GCOE), Tokyo, Japan Abstract Background The cause of autoimmunity, which is unknown, is investigated from a different [...]

[Continue reading...]
Filed Under: Vaccine Related Research, Vaccine Science Tagged With: ,

Belief not science is behind flu jab, new report says

November 29, 2012 By Leave a Comment
science-health[1]

By Jeanne Lenzer An independent meta-analysis of vaccines against influenza has found that claims of benefit have been significantly exaggerated. The report, released last month by the University of Minnesota’s Center for Infectious Disease Research and Policy, was based on a comprehensive review of data published from 1967 to 2012.1 Evidence for “consistent high-level protection [...]

[Continue reading...]
Filed Under: Immunization Practices, Seasonal Flu, Vaccine Science, World News Tagged With: , ,